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We have identified the site of molecular interaction
between nitric oxide (NO) and p21ras responsible for
initiation of signal transduction. We found that p21ras
was singly S-nitrosylated and localized this modifica-
tion to a fragment of p21ras containing Cys118. A mutant
form of p21ras, in which Cys118 was changed to a serine
residue and termed p21rasC118S, was not S-nitrosylated.
NO-related species stimulated guanine nucleotide ex-
change on wild-type p21ras, resulting in an active form,
but not on p21rasC118S. Furthermore, in contrast to pa-
rental Jurkat T cells, NO-related species did not stimu-
late mitogen-activated protein kinase activity in cells
transfected with p21rasC118S. These data indicate that
Cys118 is a critical site of redox regulation of p21ras, and
S-nitrosylation of this residue triggers guanine nucleo-
tide exchange and downstream signaling.
It is well known that signal transduction pathways initiated
by extracellular ligands are dependent on protein-protein in-
teractions for propagation and amplification of their signal.
Many of these interactions lead to phosphorylation events. For
example, receptor-tyrosine kinases require a series of protein
interactions utilizing SH2 and SH3 domains of adaptor pro-
teins to generate an activated form of p21ras, a critical signaling
enzyme (1–3).
Recent studies have identified reactive free radicals as cen-
tral participants in certain signaling events (4–7). Enhancing
free radical destruction, either enzymatically or chemically,
prevented ligand-stimulated transcription factor (8) and mito-
gen-activated protein (MAP)1 kinase (4) activation and also
prevented smooth muscle cell mitogenesis and chemotaxis (4).
Thus, a role is emerging for reactive free radicals in mediating
signal transduction.
Among the many recently discovered functions of NO, a role
in signaling has surfaced (9). Although soluble guanylyl cyclase
is an important target of NO in mediating some of its physio-
logic functions such as the regulation of blood pressure (10, 11),
other signaling events, some culminating in transcriptional
activation, may be cGMP-independent (12–15). Our studies
have focused on how NO initiates cGMP-independent signaling
within cells (16, 17). We have identified p21ras as a critical
target of NO and other redox modulators (17–19). Here, we
sought an understanding of the structural basis of the NO-
p21ras interaction in the hope of gaining insight into how redox
signaling is achieved.
MATERIALS AND METHODS
Preparation of p21ras Proteins—p21ras(1–166) was expressed and pu-
rified as described previously (20). p21rasC118S(1–166) was expressed
and purified similarly.
Generation of p21rasC118S cDNA Constructs—Codon 118 of trun-
cated (codons 1–166) Ha-ras cDNA was mutated from TGT (cysteine) to
TCT (serine) using the polymerase chain reaction. The generated cDNA
fragment was then sequenced (Sequenase) and cloned into the pATras
bacterial expression vector. To generate full-length p21rasC118S an
NcoI/BamHI fragment (encoding residues 111–166 of the ras(1–166)
mutant) was exchanged for a 0.8-kilobase fragment encoding residues
111–189 plus 39-noncoding region and the coding junction sequenced. A
BglII/BamHI fragment encoding full-length Ras(C118S) was then sub-
cloned into the BamHI site of the pCDNA3 mammalian expression
plasmid and orientation confirmed by BstXI digestion.
CNBr Digestion and ESI-MS Analysis of p21ras —One small crystal
of CNBr (Fluka) was added to 100 pmol of p21ras in 20 ml of 0.1 N HCl
in a 0.5-ml polypropylene tube. Digestion was carried out at room
temperature for 10 min prior to analysis by ESI-MS. After 10 min,
samples were directly electrosprayed into a Finnigan-MAT TSQ-700
triple quadrupole instrument for analysis of S-nitrosylation exactly as
we described previously (21).
Preparation of NO Solutions—NO solutions were prepared as we
described previously (17). Briefly, a solution of 20 mM ammonium bi-
carbonate solution, pH 8.0, in a rubber-stoppered tube was sparged for
15 min with N2 and then 15 min with NO gas (Matheson Gas, East
Rutherford, NJ). This resulted in a saturated solution of NO (1.25 mM).
This solution also contained higher oxides of NO which were not
quantified.
GTPase Assay—GDP-preloaded p21ras or p21rasC118S was analyzed
for guanine nucleotide exchange activity as we described previously
(17). Basal rates of hydrolysis of [g-32P]GTP were 24.6 6 6 fmol of PO4
2
released/min/mg for the wild-type enzyme and 18.4 6 5 fmol/min/mg for
p21rasC118S.
Cell Transfection and Culture—The human T cell line Jurkat was
grown in RPMI 1640 containing 2% L-glutamine and 10% fetal calf
serum. For transfection cells were washed in serum-free medium and
resuspended to 1–5 3 106 cells/ml in serum-free medium. Liposomes (50
ml of Lipofectin, Life Technologies, Inc.) were mixed with a solution of
10 mg of p21rasC118S plasmid in 150 ml of sterile water. This was then
added to 1 ml of culture and placed into culture flasks. After incubation
for 24 h at 37 °C and 5% CO2, the cells were supplemented with 3 ml of
selection medium (RPMI 1640 containing 10% fetal calf serum, 2%
L-glutamine, and 1 mg/ml G418 (Life Technologies, Inc.)). After another
24 h, cells were resuspended and maintained in the selection medium.
Mock transfected cells did not receive any DNA. After 3–4 weeks in
selection medium, transfected cells were analyzed for p21ras levels via
Western blotting.
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MAP Kinase Activity—MAP kinase activity was measured in an in
vitro kinase assay using myelin basic protein as a substrate, as we
described previously (18). Briefly, serum-starved cells (24 h, 5 3 106)
were treated for 30 min at 37 °C, pelleted, and then resuspended in 300
ml of RIPA buffer containing 20 mM Tris, pH 7.4, 137 mM NaCl, 2 mM
EDTA, 1% Triton X-100, 25 mM b-glycerophosphate, 1 mM NaVO3, 2 mM
NaPPi, 20% glycerol, 1 mM phenylmethylsulfonyl fluoride, and 10 mg/ml
leupeptin. Samples were vortexed, left on ice for 15 min, and then
microcentrifuged for 2 min. Protein A-Sepharose prebound to anti-
ERK1 or ERK2 (Santa Cruz Biotechnology) was added to supernatants
(5 mg/sample). After 1 h at 4 °C, samples were washed twice with RIPA
buffer and twice with kinase buffer (25 mM Hepes, pH 7.4, 25 mM
b-glcerophosphate, 25 mM MgCl2, 2 mM dithiothreitol, and 0.1 mM
NaVO3). After the final wash, samples were resuspended in 20 ml of
kinase buffer, and 1 mg of myelin basic protein was added along with 22
ml of 10 mCi/nmol [g-32P]ATP. After 20 min at 30 °C, 4 ml of 6 3
Laemmli sample buffer containing 100 mM dithiothreitol was added,
and samples were boiled for 2 min. Samples were run on 15% sodium
dodecyl sulfate-polyacrylamide gels and were analyzed via a Phosphor-
Imager (Molecular Dynamics).
RESULTS
Localization of the Site of S-Nitrosylation on p21ras—Our
earlier studies correlated a single S-nitrosylation event on full-
length p21ras with enhanced guanine nucleotide exchange (17).
In the present in vitro studies, p21ras lacking the carboxyl-
terminal 23 amino acids is used. This form of p21ras is com-
monly used for in vitro studies and possesses biochemical ac-
tivity identical to that of the wild-type enzyme (22). To identify
the exact site of S-nitrosylation, we took advantage of the fact
that cleavage of p21ras at Met residues with CNBr yields three
major fragments each containing a single Cys residue (Fig. 1).
We monitored each of the Cys residues for S-nitrosylation by
subjecting p21ras to CNBr digestion followed by analysis using
ESI-MS. In this ESI-MS assay, the molecular mass of samples
treated with NO is compared with that of untreated samples.
An increase in mass of 296 1 Da (the mass of NO, 30 Da, minus
the mass of the substituted proton) and its lability to increased
energy input are indicative of S-nitrosylation (21). As seen in
Table I, CNBr digestion of p21ras yielded a fragment with a
molecular mass of 6,223 6 2 Da, corresponding to Fragment 3
(Fig. 1). Upon treatment of p21ras with NO and subsequent
cleavage with CNBr, Fragment 3 had a new mass clearly in-
dicative of S-nitrosylation (Table I); that is, the mass of Frag-
ment 3 from NO-treated p21ras was equal to that of the unmod-
ified Fragment 3 (6,223 Da) plus that of NO (30 Da). This
fragment contains Cys118, and thus this Cys residue is the
likely target of NO. It is possible that Fragments 1 and 2 (Fig.
1) were not observed because of inter- and intramolecular hy-
drophobic interactions that precluded their solubilization.
To confirm that Cys118 was indeed the site of S-nitrosylation,
we generated a form of p21ras identical to the wild-type en-
zyme, except that Cys118 was modified to a Ser residue (re-
ferred to as p21rasC118S). This modification only changes the
sulfur atom of Cys118 to oxygen, thus reducing the mass of the
enzyme by 16 Da to 18,836 Da. We treated wild-type p21ras
with NO under conditions in which we achieved approximately
50% S-nitrosylation. Analysis by ESI-MS revealed the parent
enzyme (mass 5 18,852 Da) and a singly S-nitrosylated deriv-
ative (mass 5 18,882 Da, Table I). Treatment of p21rasC118S
with NO under identical conditions resulted in no S-nitrosy-
lated product but only the parent enzyme (Table I). These data
identify Cys118 as the molecular target of NO on p21ras.
Cys118 as the Molecular Trigger for NO Signaling—Having
established that Cys118 is the site of interaction of NO on
p21ras, we examined whether this S-nitrosylation was respon-
sible for NO-induced p21ras activation and subsequent down-
stream signaling events. We have found previously that NO
and other free radicals induce guanine nucleotide exchange on
p21ras in cells and in vitro (17–19). Therefore, we examined
whether NO could induce nucleotide exchange on GDP-pre-
loaded p21rasC118S in vitro. Direct measurement of exchange
relies on a filter binding assay to which our p21ras(1–166)
protein does not bind quantitatively (22, 23). Therefore, to
measure exchange, GDP-preloaded p21ras is treated with NO in
the presence of [g-32P]GTP, and hydrolyzed 32Pi is quantified.
We have previously shown this to be a measure of exchange in
our system (17). As seen in Fig. 2, NO potently stimulated
[g-32P]GTP hydrolysis of GDP-preloaded wild-type p21ras (open
circles). In contrast, NO had almost no effect on the exchange
rate of p21rasC118S (Fig. 2, closed circles). The basal rates of
hydrolysis for the two enzymes were similar (24.6 6 6 fmol of
PO4
2 released/min/mg for the wild-type enzyme and 18.4 6 5
fmol/min/mg for p21rasC118S). A clear biphasic curve of acti-
vation and subsequent inhibition by higher concentrations of
NO was seen. We and others have previously seen this type of
biphasic behavior of NO in many systems (15, 17, 24). The
inhibitory component may be due to nonspecific noxious effects
of high concentrations of NO and its higher oxides or due to
quenching (25). These data indicate that interaction of NO with
Cys118 is required for NO-induced guanine nucleotide exchange
on p21ras.
Since NO and other redox modulators can stimulate several
biochemical events downstream of p21ras, such as nuclear fac-
tor kB translocation and MAP kinase activity (15, 18, 26), we
FIG. 1. Predicted CNBr fragmentation and location of Cys res-
idues of p21ras. The sequence of p21ras(1–166) is indicated. Cleavage
at Met residues with CNBr (indicated by arrowheads) yields three
major fragments. Fragment 1 (green underline) contains Cys51 and has
a mass of 7,203 Da. Fragment 2 (purple underline) contains Cys80 and
has a mass of 4,540 Da. Fragment 3 (red underline) contains Cys118 and
has a mass of 6,225 Da.
TABLE I
ESI-MS analysis of various p21ras preparations
Analyte Molecular mass Differencea
Da Da
CNBr-cleaved p21ras 6,223 6 2
CNBr-cleaved p21ras 1 NO 6,253 6 2 30
p21ras 18,852 6 2
p21ras 1 NO 18,882 6 2 30
p21ras (C118S) 18,836 6 2
p21ras (C118S) NO 18,836 6 2 0
a Difference refers to the mass difference between the untreated and
NO-treated preparations within each group.
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examined whether Cys118 on p21ras is a target for NO in cells.
Using Jurkat T cells mock transfected or stably transfected
with an expression plasmid encoding a full-length version of
p21rasC118S (i.e. residues 1–189), we examined the ability of
NO to activate MAP kinase activity. Immunoprecipitation of
the MAP kinases ERK1 and ERK2 from wild-type cells treated
with NO-generating compounds S-nitroso-N-acetylpenicilla-
mine or sodium nitroprusside resulted in enhanced phospho-
rylation of the ERK substrate (Fig. 3A, open bars). In contrast,
Jurkat T cells stably expressing p21rasC118S(1–189) did not
respond to NO in this in vitro kinase assay (Fig. 3A, hatched
bars). These transfected cells expressed 7–10-fold more p21ras
than the wild-type cells as determined by Western blotting
with anti-p21ras antibody, Y13-259 (Fig. 3B). This antibody
cannot distinguish between wild-type and p21rasC118S, sug-
gesting that although endogenous p21ras was not specifically
inhibited, ectopic expression of high levels of mutant p21ras
apparently prevented its signaling. This dominant negative
activity of p21rasC118S toward NO action may be due to its
high level of expression. The pool of effectors available for
wild-type p21ras to interact with may be reduced greatly by
overexpression of p21rasC118S, perhaps due to their sequestra-
tion. Another possibility is that MAP kinase activity is sup-
pressed in the mutant cells. To test this, we treated parental
and transfected cells with phorbol myristate acetate (100 ng/
ml) and the calcium ionophore A23187 (500 ng/ml) for 5 min.
We found that these agents, which bypass p21ras in activating
MAP kinase, stimulated MAP kinase activity in both cell types
(i.e. 221 6 8 versus 261 6 9% of control, parental versus trans-
fected). Thus, NO donors did not stimulate MAP kinase activity
in p21rasC118S-transfected cells although these cell harbored a
functional MAP kinase system. These data indicate that Cys118
is indeed the target of NO on p21ras responsible for triggering
downstream signal transduction.
DISCUSSION
Redox regulation of signaling pathways currently presents
several conceptual riddles. These include identifying the source
of regulatory redox species, maintaining specificity, and iden-
tifying the redox target. Our earlier work demonstrated a func-
tional requirement for p21ras in NO signaling (17). Here, we
have focused on identifying the molecular target of NO on
p21ras. We have identified Cys118 as the critical site of S-
nitrosylation. The crystal structure of p21ras is well defined (27,
28), and modeling studies show that Cys118 is the most surface
accessible of the three Cys residues in our p21ras preparation.
Using the program X-PLOR (Molecular Simulations, Inc.) the
solvent accessible surface of p21ras complexed to GDP (coordi-
nates obtained from the NMR solution structure) was calcu-
lated using a 1.4 Å radius probe. Whereas the solvent accessi-
bility of Cys51 and Cys80 side chains were similar and fairly
shielded from the solvent, Cys118 was solvent exposed. The
buried nature of residues Cys80 and Cys51 provides a structural
basis of why a single S-nitrosylation occurs on p21ras upon
exposure to NO.
A mechanistic understanding of how S-nitrosylated Cys118
leads to enhanced guanine nucleotide exchange will likely be
provided by solving its x-ray crystal structure. However, some
insight is gained from considering what is currently known
about p21ras structure and function. Cys118 is located within a
highly conserved region (NKXD) of the ras superfamily and
indeed all GTP-binding protein sequences. This NKXD motif,
FIG. 2. Effect of NO on GTPase activity of p21ras and
p21rasC118S. GDP-preloaded wild-type (wt) p21ras or p21rasC118S was
exposed to the indicated concentrations of NO for 10 min prior to assay
of [g-32]GTP hydrolysis as described under “Materials and Methods.”
Basal rates for the two enzymes were 24.6 6 6 fmol of PO4
2 released/
min/mg for the wild-type enzyme and 18.4 6 5 fmol/min/mg for
p21rasC118S. Data represent mean 6 S.D. of three experiments.
FIG. 3. Effect of NO on MAP kinase activity in parental or
transfected Jurkat cells. Panel A, mock transfected Jurkat cells (wt,
open bars) or Jurkat cells stably transfected with p21rasC118S (hatched
bars) were treated with either S-nitroso-N-acetylpenicillamine (SNAP)
for 10 min or sodium nitroprusside (SNP) for 30 min prior to lysis and
analysis of ERK1 and ERK2 activities as described under “Materials
and Methods.” Data represent mean 6 S.D. of three experiments. Panel
B, cells (from panel A) were lysed, run on sodium dodecyl sulfate-
polyacrylamide gel electrophoresis, and Western blotted with an anti-
ras antibody. Mt, p21rasC118S-expressing cells; Wt, parental wild-type
cells.
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in which Cys118 is the variable X residue in p21ras, interacts
directly with the guanine nucleotide ring of GTP and GDP and
with other nucleotide-binding loops of the protein (29). Inde-
pendent mutation of residue 116, 117, or 119 leads to an in-
creased dissociation rate of bound nucleotide, resulting in an
increased rate of nucleotide exchange (30). Although our
p21rasC118S mutant had basal rates of guanine nucleotide
exchange similar to those of the wild-type protein, it is possible
that S-nitrosylation results in an alteration in protein-GDP
contact, resulting in nucleotide exchange.
The presence of a redox-active residue in such a critical
domain suggests that its conservation may reveal enzymes and
transductional systems that may be similarly regulated. In the
ras superfamily, Ha-, Ki-, and N-ras, rap1A, rap1B, rab1, and
rab3 contain a Cys residue in this conserved region. In con-
trast, ral, tc21, R-ras, rap2, and rho gene products do not.
Within the ras subfamily, this Cys residue is conserved from
slime mold to man. Such conservation suggests that this mo-
lecular redox trigger is an important mechanism by which cells
respond to reactive free radicals.
It is likely that this molecular switch is regulated by cellular
antioxidant levels. We have shown previously that reducing
cellular glutathione levels renders the p21ras signaling path-
way dramatically more sensitive to redox activation (18). Ac-
cording to this model, as glutathione is oxidized, the Cys switch
on p21ras becomes available for modification, and a prepro-
grammed signaling cascade is initiated. Glutathione or other
low molecular weight thiols likely play an important role in
S-nitrosylation of p21ras. NO, under anaerobic conditions, can-
not participate in S-nitrosylation. NO must be converted to a
redox active form such as nitrosonium ion (NO1; Ref. 9). This
occurs rapidly in the presence of metals or thiols, and thus
S-nitrosoglutathione may be a crucial reservoir of redox active
NO.
Such a redox-triggered signaling pathway may also provide a
mechanistic understanding of some recent observations identi-
fying a requirement for reactive free radicals in mediating
platelet-derived growth factor (PDGF) signaling. In those stud-
ies (4), PDGF stimulated H2O2 production in vascular smooth
muscle cells. When H2O2 production was blocked, PDGF-in-
duced enhancement of MAP kinase activity, chemotaxis, and
DNA synthesis was prevented. Many of these PDGF-dependent
events require p21ras, and thus the redox-sensitive target,
Cys118, is likely to be involved in this reactive free radical-de-
pendent signaling cascade. Modification of Cys by redox mod-
ulators other than NO, such as hydroxyl radical or heavy met-
als, would necessitate a Cys modification that is chemically
different from the S-nitrosylation described herein. However,
the structural alterations may ultimately be the same.
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